Compare Stocks

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HLS HLS Therapeutics	C$4.92 +0.6%	C$4.23	C$3.34 ▼ C$7.12	C$157.05M	1.16	9,973 shs	601 shs
NXS Nexus Gold	C$0.02 +33.3%	C$0.02	C$0.02 ▼ C$0.10	C$837K	0.85	68,853 shs	42,000 shs
OGI Organigram	$1.92 +2.4%	$2.10	$0.97 ▼ $2.91	$197.63M	1.09	1.37 million shs	482,112 shs

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HLS HLS Therapeutics	+0.61%	-1.80%	+21.48%	+21.48%	-18.00%
NXS Nexus Gold	0.00%	0.00%	-20.00%	+33.33%	+300.00%
OGI Organigram	+2.19%	-8.78%	-15.77%	+0.54%	-14.77%

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (Ad)

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HLS HLS Therapeutics	0.0452 of 5 stars	1.1	0.0	1.7	0.0	0.4	0.8	0.0
NXS Nexus Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OGI Organigram	0.2146 of 5 stars	0.0	2.0	0.0	0.0	2.5	0.0	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HLS HLS Therapeutics	2.25	Hold	C$4.58	-7.01% Downside
NXS Nexus Gold	N/A	N/A	N/A	N/A
OGI Organigram	3.00	Buy	N/A	N/A

Current Analyst Ratings

Latest HLS, OGI, and NXS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2024	OGI Organigram	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
3/18/2024	HLS HLS Therapeutics	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$6.50 ➝ C$5.00
3/15/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$4.35 ➝ C$4.15
2/22/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$5.00 ➝ C$4.35
2/6/2024	HLS HLS Therapeutics	Clarus Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HLS HLS Therapeutics	C$63.07M	2.49	C$0.32 per share	15.22	C$3.06 per share	1.61
NXS Nexus Gold	N/A	N/A	C$0.00 per share	10.00	C($0.01) per share	N/A
OGI Organigram	$120.01M	1.65	N/A	N/A	$2.48 per share	0.77

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HLS HLS Therapeutics	-C$27.53M	-C$1.16	N/A	∞	N/A	-43.65%	-24.69%	-2.87%	5/9/2024 (Estimated)
NXS Nexus Gold	-C$1.92M	-C$0.06	N/A	∞	N/A	N/A	-1,307.50%	-53.77%	5/29/2024 (Estimated)
OGI Organigram	-$184.34M	-$0.80	N/A	N/A	N/A	-173.48%	-30.94%	-27.70%	4/23/2024 (Estimated)

Latest HLS, OGI, and NXS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/14/2024	Q4 2023	HLS HLS Therapeutics	-C$0.13	-C$0.18	-C$0.05	-C$0.13	C$21.83 million	C$21.60 million
2/13/2024	Q1 2024	OGI Organigram	-$0.10	-$0.14	-$0.04	-$0.14	$28.61 million	$26.78 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HLS HLS Therapeutics	C$0.20	4.07%	N/A	N/A	N/A
NXS Nexus Gold	N/A	N/A	N/A	N/A	N/A
OGI Organigram	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HLS HLS Therapeutics	89.69	1.65	1.01
NXS Nexus Gold	14,120.33	0.05	0.38
OGI Organigram	N/A	4.28	2.11

Ownership

Institutional Ownership

Company	Institutional Ownership
HLS HLS Therapeutics	59.62%
NXS Nexus Gold	N/A
OGI Organigram	34.63%

Insider Ownership

Company	Insider Ownership
HLS HLS Therapeutics	0.49%
NXS Nexus Gold	0.51%
OGI Organigram	0.09%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
HLS HLS Therapeutics	91	31.92 million	N/A	Not Optionable
NXS Nexus Gold	N/A	41.87 million	N/A	Not Optionable
OGI Organigram	984	103.20 million	103.11 million	Optionable

HLS, OGI, and NXS Headlines

Source	Headline
	Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy" americanbankingnews.com - April 16 at 4:50 AM
	Organigram (NASDAQ:OGI) Lifted to Buy at Alliance Global Partners marketbeat.com - April 15 at 9:11 AM
	Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI) markets.businessinsider.com - April 11 at 1:36 PM
	Organigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year stockhouse.com - April 10 at 5:10 PM
	Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI) marketbeat.com - April 5 at 8:21 AM
	Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales finance.yahoo.com - April 3 at 8:37 AM
	Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales businesswire.com - April 3 at 8:06 AM
	Organigram Successfully Closes Previously Announced Underwritten Public Offering businesswire.com - April 2 at 8:51 AM
	Organigram (NASDAQ:OGI) Stock Price Down 6.3% marketbeat.com - March 30 at 12:43 AM
	Why OrganiGram (OGI) Might Surprise This Earnings Season zacks.com - March 28 at 9:56 AM
	Why OrganiGram (OGI) Stock Is Diving msn.com - March 27 at 3:18 PM
	Organigram Sells Units to Raise C$25 MIllion newcannabisventures.com - March 27 at 10:18 AM
	Organigram Announces Pricing of Overnight Marketed Public Offering businesswire.com - March 27 at 8:56 AM
	Organigram Announces Launch of Overnight Marketed Public Offering businesswire.com - March 26 at 7:06 PM
	Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment businesswire.com - March 26 at 1:36 PM
	OGI Sep 2024 6.000 call finance.yahoo.com - March 26 at 12:10 AM
	OGI Jun 2024 4.000 put finance.yahoo.com - March 26 at 12:10 AM
	Organigram ‘assessing options’ after unfavorable ruling on cannabis edibles mjbizdaily.com - March 26 at 12:10 AM
	The Marijuana Stocks Could See A Rise This Week marijuanastocks.com - March 24 at 9:40 AM
	Organigram Receives Health Canada's Final Redetermination on Jolts businesswire.com - March 22 at 7:00 PM
	Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5 investorplace.com - March 21 at 4:05 PM
	OGI Apr 2024 2.000 put finance.yahoo.com - March 17 at 12:08 AM
	Top Marijuana Stocks For Trading Today 2024 marijuanastocks.com - March 6 at 9:06 AM
	2 Top Marijuana Penny Stocks with High Momentum Before March 2024 marijuanastocks.com - March 2 at 11:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024 1:50 PM
View Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
3 Stocks About to Join the Rate Cut Party
March 21, 2024 7:12 AM
View 3 Stocks About to Join the Rate Cut Party
Prologis Stock Leading U.S. Logistics Boom
April 17, 2024 7:50 AM
View Prologis Stock Leading U.S. Logistics Boom
Buckle Up or Bail Out? The Self-Driving Taxi Market's Risky Ride
April 16, 2024 9:45 AM
View Buckle Up or Bail Out? The Self-Driving Taxi Market's Risky Ride

All Headlines

Company Descriptions

HLS Therapeutics

TSE:HLS

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

Nexus Gold

CVE:NXS

Nexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa and Canada. The company explores for gold, silver, manganese, bauxite, copper, nickel, lead, zinc, and limestone/marble deposits. Its flagship property is the Bouboulou project located in Burkina Faso, West Africa. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.

Organigram

NASDAQ:OGI

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial